Mr Cornelius Rene

Consultant Ophthalmologist


Specialises in

I qualified from Middlesex Hospital Medical School in 1985 and embarked on a career in ophthalmology in 1987. After completing junior ophthalmic training posts in London and the South East, I moved to Birmingham where I completed my higher surgical training. I gained subspecialty training in oculoplastic, lacrimal and orbital surgery in two clinical fellowships at Queen’s Medical Centre (Nottingham) and Moorfields Eye Hospital (London) respectively.

I have been a consultant ophthalmologist since 1998 and provide a subspecialty service in oculoplastic, lacrimal and orbital surgery at Addenbrooke’s Hospital (where I am the service lead) and Hinchingbrooke Hospital. Since 2005 I have served as the treasurer of the British Oculoplastic Surgery Society and I am also the Clinical Governance Lead for my subspecialty group in the East Anglia region. Although my practice is almost exclusively subspecialty based, I maintain an interest in general ophthalmology.


Treatment information

Some of the principal treatments carried out by Mr Cornelius Rene at Spire include:


Get in touch


Marketing Information

Spire would like to provide you with marketing information about products and services offered by Spire and by selected third-party partners. If you do not consent for us to process your personal data for marketing activities, we will still be able to contact you about your enquiry.

We may contact you by email, SMS or phone about your enquiry. If we try to contact you by phone (mobile and/or landline) and you are not available, we may leave you a voicemail message. We may also use your details to contact you about patient surveys we use for improving our service or monitoring outcomes, which are not a form of marketing.

Submit my enquiry

Additional information


Consultant Ophthalmic Surgeon, Hinchingbrooke NHS Trust Hospital, Huntingdon, Cambs.

Consultant Ophthalmic Surgeon, Addenbrooke's Hospital NHS Trust, Cambridge.

Mr Cornelius René holds less than 0.1% of the shares in Spire Healthcare Group plc.